Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients
Recruiting
Observational Study
Acute Kidney Injury
Fluid Overload
Fluid Overload in Dialysis Patients
Critical Illness
Renal Replacement Therapy for Acute Kidney Injury in ICU
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 128 (estimated)
- Sponsor
- Hospital Las Higueras · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Acute kidney injury (AKI) is common in critically ill patients and is frequently associated with fluid overload, which can worsen clinical outcomes. Continuous renal replacement therapy (CRRT) allows fluid removal through net ultrafiltration (UFNET), but some patients develop hemodynamic instability or signs of poor tissue perfusion during this process.
The purpose of this prospective observation…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* Admission to an Intensive Care Unit
* Acute kidney injury according to KDIGO criteria
* Prescription of continuous renal replacement therapy (CRRT) with net ultrafiltration
* Clinical stability considered sufficient to initiate net ultrafiltration according to …
Contacts